| |
Allicor
|
Placebo
|
|---|
|
Variable
|
All
|
Men
|
Women
|
All
|
Men
|
Women
|
|---|
| |
(n = 26)
|
(n = 14)
|
(n = 12)
|
(n = 25)
|
(n = 14)
|
(n = 11)
|
|---|
|
Age, years
|
56.7 ± 1.8
|
53.6 ± 1.9
|
60.3 ± 2.9
|
56.3 ± 1.7
|
52.6 ± 1.9
|
60.9 ± 2.4$
|
|
SBP, mm Hg
|
134.2 ± 2.8
|
130.4 ± 3.8
|
138.8 ± 3.9
|
130.8 ± 3.1
|
129.3 ± 4.4
|
132.7 ± 4.3
|
|
DBP, mm Hg
|
82.5 ± 1.9
|
82.1 ± 2.6
|
82.9 ± 2.9
|
81.0 ± 1.7
|
81.4 ± 2.5
|
80.5 ± 2.4
|
|
BMI, kg/m2
|
27.0 ± 0.9
|
27.2 ± 1.2
|
26.8 ± 1.5
|
27.9 ± 0.9
|
27.3 ± 1.0
|
28.6 ± 1.6
|
|
DM, n
|
0
|
0
|
0
|
0
|
0
|
0
|
|
LVH, n
|
3
|
2
|
1
|
3
|
2
|
1
|
|
MI, n
|
17
|
12
|
5
|
13
|
10
|
3
|
|
Smoking, n
|
8*
|
7
|
1
|
4
|
4
|
0
|
- SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index, DM, type 2 diabetes mellitus; LVH, left ventricular hypertrophy; MI, myocardial infarction in anamnesis.
- * - significant difference from placebo, p < 0.05;
- $ - significant difference between men and women within the group, p < 0.05.
